Acknowledgement
This research was supported by a grant from the Ministry of Food and Drug Safety to operation of the Regional Pharmacovigilance Center in 2016.
References
- Letko, E., D. N. Papaliodis, G. N. Papaliodis, Y. J. Daoud, A. R. Ahmed, and C. S. Foster. 2005. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann. Allergy Asthma Immunol. 94: 419-436. https://doi.org/10.1016/S1081-1206(10)61112-X
- Pereira, F. A., A. V. Mudgil, and D. M. Rosmarin. 2007. Toxic epidermal necrolysis. J. Am. Acad. Dermatol. 56: 181-200. https://doi.org/10.1016/j.jaad.2006.04.048
- Torres, M. J., C. Mayorga, and M. Blanca. 2009. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J. Investig. Allergol. Clin. Immunol. 19: 80-90.
- Tohyama, M., and K. Hashimoto. 2012. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis. Curr. Opin. Allergy Clin. Immunol. 12: 376-382. https://doi.org/10.1097/ACI.0b013e328355b865
- Harr, T., and L. E. French. 2010. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet. J. Rare Dis. 5: 39.
- Barron, S. J., M. T. Del Vecchio, and S. C. Aronoff. 2015. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a metaanalysis with meta-regression of observational studies. Int. J. Dermatol. 54: 108-115. https://doi.org/10.1111/ijd.12423
- Shiohara, T., and Y. Kano. 2007. A complex interaction between drug allergy and viral infection. Clin. Rev. Allergy Immunol. 33: 124-133. https://doi.org/10.1007/s12016-007-8010-9
- Blazquez, A. B., J. Cuesta, and C. Mayorga. 2011. Role of dendritic cells in drug allergy. Curr. Opin. Allergy Clin. Immunol. 11: 279-284. https://doi.org/10.1097/ACI.0b013e3283489bab
- Kim, K. J., D. P. Lee, H. S. Suh, M. W. Lee, J. H. Choi, K. C. Moon, and J. K. Koh. 2005. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients. Acta Derm. Venereol. 85: 497-502. https://doi.org/10.1080/00015550510038232
- Mockenhaupt, M. 2011. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev. Clin. Immunol. 7: 803-813. https://doi.org/10.1586/eci.11.66
- Beldomenico, P. M., S. Telfer, S. Gebert, L. Lukomski, M. Bennett, and M. Begon. 2008. Poor condition and infection: a vicious circle in natural populations. Proc. Biol. Sci. 275: 1753-1759. https://doi.org/10.1098/rspb.2008.0147
- Segel, G. B., and J. S. Halterman. 2008. Neutropenia in pediatric practice. Pediatr. Rev. 29: 12-23. https://doi.org/10.1542/pir.29-1-12
- Sohn, K. H., S. Y. Oh, K. W. Lim, M. Y. Kim, S. Y. Lee, and H. R. Kang. 2015. Sorafenib induces delayed-onset cutaneous hypersensitivity: a case series. Allergy Asthma Immunol. Res. 7: 304-307. https://doi.org/10.4168/aair.2015.7.3.304
- Kim, E. J., H. Lim, S. Y. Park, S. Kim, S. Y. Yoon, Y. J. Bae, H. S. Kwon, Y. S. Cho, H. B. Moon, and T. B. Kim. 2014. Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen. Asia Pac. Allergy 4: 68-72. https://doi.org/10.5415/apallergy.2014.4.1.68
- Shimizu, T. 2005. Role of macrophage migration inhibitory factor (MIF) in the skin. J. Dermatol. Sci. 37: 65-73. https://doi.org/10.1016/j.jdermsci.2004.08.007
- Alam, R. 1997. Chemokines in allergic inflammation. J. Allergy Clin. Immunol. 99: 273-277. https://doi.org/10.1016/S0091-6749(97)70042-3
- Nomura, Y., M. Aihara, S. Matsukura, Y. Ikezawa, T. Kambara, Y. Aihara, Y. Takahashi, and Z. Ikezawa. 2011. Evaluation of serum cytokine levels in toxic epidermal necrolysis and Stevens-Johnson syndrome compared with other delayed-type adverse drug reactions. J. Dermatol. 38: 1076-1079. https://doi.org/10.1111/j.1346-8138.2010.01170.x
- Yawalkar, N., M. Shrikhande, Y. Hari, H. Nievergelt, L. R. Braathen, and W. J. Pichler. 2000. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J. Allergy Clin. Immunol. 106: 1171-1176. https://doi.org/10.1067/mai.2000.110922
- Halevy, S., and E. Livni. 1997. The role of macrophage migration inhibition factor in toxic epidermal necrolysis. Int. J. Dermatol. 36: 776-778. https://doi.org/10.1046/j.1365-4362.1997.00043.x